Transgenic Group Inc. (TYO:2342)

Transgenic Group Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	2,259	2,134	2,555	2,478	3,459	4,618
Short-Term Investments	-	-	-	-	-	5
Cash & Short-Term Investments	2,259	2,134	2,555	2,478	3,459	4,623
Cash Growth	-1.95%	-16.48%	3.11%	-28.36%	-25.18%	52.57%
Receivables	1,418	1,166	1,211	1,336	1,076	893
Inventory	2,523	2,472	2,221	2,227	2,238	1,714
Other Current Assets	578	936	711	508	789	479
Total Current Assets	6,778	6,708	6,698	6,549	7,562	7,709
Property, Plant & Equipment	1,975	1,991	2,055	2,142	1,991	1,992
Long-Term Investments	480	362	246	264	230	234
Goodwill	472	484	531	512	557	365
Other Intangible Assets	22	21	22	21	10	12
Long-Term Deferred Tax Assets	-	167	31	321	320	126
Other Long-Term Assets	1	2	2	-	1	2
Total Assets	9,728	9,735	9,586	9,810	10,672	10,440

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	333	415	413	276	408	256
Accrued Expenses	63	64	69	71	23	16
Short-Term Debt	1,205	565	680	448	170	390
Current Portion of Long-Term Debt	559	571	538	466	492	337
Current Portion of Leases	-	-	-	15	17	16
Current Income Taxes Payable	248	279	275	282	341	724
Other Current Liabilities	1,462	1,954	1,297	876	1,292	920
Total Current Liabilities	3,870	3,848	3,272	2,434	2,743	2,659
Long-Term Debt	840	952	1,356	1,307	1,706	1,031
Long-Term Leases	-	-	-	19	31	44
Pension & Post-Retirement Benefits	70	70	68	37	40	24
Long-Term Deferred Tax Liabilities	-	17	12	-	-	-
Other Long-Term Liabilities	15	10	23	16	31	47
Total Liabilities	4,795	4,897	4,731	3,813	4,551	3,805

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	50	50	50	50	50	50
Additional Paid-In Capital	3,856	3,856	3,857	3,861	3,869	4,109
Retained Earnings	986	850	927	2,067	2,147	2,657
Treasury Stock	-116	-116	-116	-135	-76	-300
Comprehensive Income & Other	101	139	44	50	27	15
Total Common Equity	4,877	4,779	4,762	5,893	6,017	6,531
Minority Interest	56	59	93	104	104	104
Shareholders' Equity	4,933	4,838	4,855	5,997	6,121	6,635
Total Liabilities & Equity	9,728	9,735	9,586	9,810	10,672	10,440

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	2,604	2,088	2,574	2,255	2,416	1,818
Net Cash (Debt)	-345	46	-19	223	1,043	2,805
Net Cash Growth	-	-	-	-78.62%	-62.82%	170.49%
Net Cash Per Share	-20.72	2.76	-1.14	13.27	61.92	163.41
Filing Date Shares Outstanding	16.65	16.65	16.65	16.59	16.86	16.82
Total Common Shares Outstanding	16.65	16.65	16.65	16.59	16.86	16.82
Working Capital	2,908	2,860	3,426	4,115	4,819	5,050
Book Value Per Share	292.86	286.97	285.95	355.13	356.93	388.34
Tangible Book Value	4,383	4,274	4,209	5,360	5,450	6,154
Tangible Book Value Per Share	263.19	256.65	252.74	323.01	323.29	365.92
Order Backlog	-	2,580	3,001	1,956	2,791	2,581

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error